Pharma Marketletter

Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.

Canada/USA pledge on generics for LDCs.(Brief Article)
July 26, 2004

UK pharma/NHS partnership guidance.(Association of the British Pharmac...
July 26, 2004

New discovery challenges thinking on cancer development.(Brief Article...
July 26, 2004

Growing US use of health plan web sites to access Rx data.
July 26, 2004

Single dose of BI's Viramune with zidovudine effective in PMTCT of HIV...
July 26, 2004

Venezuela replaces delisted HIV/AIDS drugs.(Brief Article)
July 26, 2004

UPDATE: Promising new data for Neurochem's Alzhemed for mild-to-modera...
July 26, 2004

South Africa: no policy change on nevirapine.(Brief Article)
July 26, 2004

Promising new results for Alzhemed.
July 26, 2004

Affymetrix and ParAllele collaborate in diabetes study.(Alliances and ...
July 26, 2004

SELDI-based immunoassay reveals new peptide variants in clinical AD sa...
July 26, 2004

Novartis beats expectations with 19% rise in 1st-half 2004 net income.
July 26, 2004

PDL in research alliance with Morphotek.(Protein Design Labs)(contract...
July 26, 2004

AOP Orphan gains EU OK for Thromboreductin.(Brief Article)
July 26, 2004

Biogen Idec selects Evotec as service provider.(Brief Article)
July 26, 2004

Protherics aims for L10 million in fund raising.(Protherics Inc.)(Brie...
July 26, 2004

Angiotech expects $3-$5M loss from stent recall.(Angiotech Pharmaceuti...
July 26, 2004

Inspire to publicly offer stock.(Inspire Pharmaceuticals Inc.)(Brief A...
July 26, 2004

2nd- qtr Visudyne sales up 22.6% to $109.3M.(Novartis AG)(Brief Articl...
July 26, 2004

Lower earnings for Japan's Kobayashi.(Kobayashi Pharmaceutical Company...
July 26, 2004

Roche's Pegasys filed for hepatitis B.(Roche Holding Ltd.)(Brief Artic...
July 26, 2004

Allergan's Botox gets FDA OK for new use.(Allergan Inc.)(Food and Drug...
July 26, 2004

Alexion prices 5 million share offering.(Alexion Pharmaceuticals Inc.)...
July 26, 2004

Pfizer revenues rise 24% in 2nd-qtr.(Pfizer Pharmaceuticals Inc.)(Brie...
July 26, 2004

Merck & Co 2nd-qtr profit dips 2%.(Merck and Company Inc.)(Brief Artic...
July 26, 2004

UPDATE: Shire's Fosrenol faces delay for US approval.(Shire Pharmaceut...
July 26, 2004

Depomed files NDA for Proquin XR.(Depomed Inc.)(Brief Article)
July 26, 2004

CancerVax licenses Cuban cancer drugs.(CancerVax Corp.)(CIMAB)(YM Bios...
July 26, 2004

UK doubles Global Fund pledge for next three years.(Brief Article)
July 26, 2004

Fast growth for intl pain management market: study.(Brief Article)
July 26, 2004

Success of Australia's clinical trial subsidies.(Brief Article)
July 26, 2004

Wyeth's 2nd-qtr profit slips, but sales climb.
July 26, 2004

Stock Commentary - Europe.(Brief Article)
July 26, 2004

Elan and Wyeth gain patents for Alzheimer's disease immunotherapy.(Bri...
July 26, 2004

Global retail Rx sales up 8% in year to May.(Brief Article)
July 26, 2004

Sanofi's Plavix ruling delayed in the USA.(Sanofi-Synthelabo S.A.)(Bri...
July 26, 2004

Atrix' Eligard six-month prostate cancer product filed in Canada.(Sano...
July 26, 2004

Berlex to invest $60M into biopharm center.(Brief Article)
July 26, 2004

Avigen moves to conserve finances.(restructuring plan)(Brief Article)
July 26, 2004

Jerini divests peptides technology unit.(Brief Article)
July 26, 2004

GSK/China deal for HIV/AIDS drugs.(Brief Article)
July 26, 2004

Vietnam Rx imports.(Brief Article)
July 26, 2004

King Pharma promotes Brian Markison to CEO.(King Pharmaceuticals Inc. ...
July 26, 2004

Integrated BioPharm to buy Hauser CRO.(Integrated Biopharma)(Hauser Co...
July 26, 2004

UCB divests films business for 320 million euros.(UCB S.A.)(Celltech)(...
July 26, 2004

Seattle and Celera to develop antibody therapies for cancer.(Celera Ge...
July 26, 2004

Alexion starts pivotal Ph III trials for pexelizumab.(Alexion Pharmace...
July 26, 2004

EC clears two-year storage duration for Schering AG's Betaferon.(Scher...
July 26, 2004

Stephen Petti becomes VP, product development at Neurobiological Techn...
July 26, 2004

Margaret Morgan joins AstraZeneca as global product PR director.(Brief...
July 26, 2004

Dendreon recruits Linda Staley as VP, information technology.(Brief Ar...
July 26, 2004

Angensys names Martha Vincent vice president, clinical R&D.(Brief Arti...
July 26, 2004

Stock Commentary - New York.(Brief Article)
July 26, 2004

Introgen calls for halt to German market trading.(Introgen Therapeutic...
July 26, 2004

Net loss higher at Vivus in 2nd qtr.(financial results)(Brief Article)
July 26, 2004

Senetek seeking strategic acquisitions.(Tri-Artisan)(Brief Article)
July 26, 2004

Schering-AG's low-dose Yasmin delayed.(Brief Article)
July 26, 2004

ImClone and B-MS plan to file for new use of Erbitux in USA.(ImClone S...
July 26, 2004

Oscient names three new VPs.(Oscient Pharmaceuticals appointed vice pr...
July 26, 2004

Epigenomics starts trading on German stock market.(Brief Article)
July 26, 2004

Ilex' clofarabine to get extra exclusivity.(Bioenvision)(Brief Article...
July 26, 2004

SPECTRUM.(securities)(Brief Article)(Illustration)
July 26, 2004

Serologicals reports 2nd-qtr 20% revenue rise.(financial reports)(Brie...
July 26, 2004

Carrington unit in vaccine delivery research deal.(DelSite Biotechnolo...
July 26, 2004

Abbott and Deltanoid in renal research.(Abbott Laboratories Inc.)(Brie...
July 26, 2004

NitroMed's BiDil achieves Ph III goals.(NitroMed Inc.)(Brief Article)
July 26, 2004

IVAX buys production plant in Mexico.(Brief Article)
July 26, 2004

Evotec raises 7.5M euros from share offering.(Evotec OAI)(Brief Articl...
July 26, 2004

MGI Pharma's 2nd-qtr sales rocket to $46.9M.(MGI Pharma Inc.)(Brief Ar...
July 26, 2004

Akzo's 2nd-qtr pharma sales slip further.(Akzo Nobel N.V.)
July 26, 2004

Xenogen announce IPO.(initial public offering )(Brief Article)
July 26, 2004

Savient changes focus to drug development.(Brief Article)
July 26, 2004

ImmuCell's 2nd-qtr loss drops 53%.(Immucell Corp.)(Brief Article)
July 26, 2004

Biomira and Phenomenome to discover cancer therapy markers.(Biomira In...
July 26, 2004

Pharmaxis pushing ahead with Phase II trial of Bronchitol.(Brief Artic...
July 26, 2004

Page 1|2|3|4|5|6|7